MCM2 and cancer: Many of the downregulated proteins were previously reported to play an important role in cancer progression, including SLC7A5, FHL2, SPATS2L, DAD1, TPD52, MCM2, PKP3, CRK, LPP, PSAT1, PKP3, TMX1, and SF3B4.